• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Spire Biomedical Awarded Grant for Dental Arch Wire Coatings

Spire Biomedical Awarded Grant for Dental Arch Wire Coatings

October 5, 2011 By MassDevice Contributors Network

NIH awards Spire a nine-month SBIR grant worth over $100,000

BEDFORD, Mass.–(BUSINESS WIRE)–Spire Biomedical, a wholly-owned subsidiary of Spire Corporation (Nasdaq: SPIR), announced today that the National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR), has awarded Spire a nine-month Small Business Innovation Research (SBIR) Phase I Grant for $114,173, to develop coatings for dental arch wires used in orthodontics. The purpose of the coatings is to reduce sliding resistance between the arch wire and bracket, lowering the force required to straighten teeth, reducing treatment times, and resulting in more predictable outcomes for the orthodontist.

“Spire Biomedical provides surface treatment and coating services to the medical device industry”
“Spire Biomedical provides surface treatment and coating services to the medical device industry,” said Mark C. Little, CEO of Spire Biomedical. “We currently process hundreds of thousands of dental arch wires every year with our IonGuard® process. This grant will help us to develop next-generation ceramic oxide coatings that promise even greater performance. The coatings will effectively decouple sliding resistance from other mechanical properties of the arch wire, providing the practitioner with new tools for solving specific patient problems. The program is targeting improved performance in nickel-titanium and titanium-molybdenum alloy wires, but the coatings should be applicable to other types of wires as well.”

About Spire Corporation

Spire Biomedical, a wholly owned subsidiary of Spire Corporation, a global solar company, provides surface treatment services for implantable medical devices. To learn more about Spire Biomedical, visit www.SpireBiomedical.com. To learn more about Spire Corporation, visit www.SpireCorp.com or email [email protected].

Certain matters described in this press release may be forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risk of dependence on market growth, competition and dependence on government agencies and other third parties for funding contract research and services, as well as other factors described in the Company’s Form 10-K and other periodic reports filed with the Securities and Exchange Commission.

Contacts

For Spire
Mark C. Little, 781-275-6000
CEO, Spire Biomedical

Filed Under: Uncategorized Tagged With: Press Release, Spire Corp.

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy